Inimmune to Play a Key Role at the World Vaccine Congress
MISSOULA, Montana, March 29, 2023 – Inimmune, a leading biotech company focused on the development of novel vaccine adjuvants, immunotherapies and delivery systems, announced today that its Chief Scientific and Strategy Officer, Jay Evans, Ph.D., and its Chief Operating Officer, David Burkhart, Ph.D., will play key roles at the World Vaccine Congress event. Dr. Evans will serve […]
